World TB Day 2020 - and it's a very different one...
Today (march 24th) is World TB day and it feels very different this year. It's because of COVID -19, of course – which is another...
Can moxa help protect us from COVID-19?
SARS Cov-2 ... COVID-19 ... nCoV19… whatever it’s called, can we help protect ourselves from it with moxa? - How dangerous is it, for...
‘Combatte Kudasai!’
Last week a friend and long-time supporter sent us a significant donation with this curious tag ‘combatte kudasai’.
The Good, the Bad … and the Significantly Absent A review of the 2019 Global TB Report
This year’s Global Report on TB was published last week by the WHO. It’s become a custom for us to comment on it on each occasion. First...
Extra-pulmonary TB - and missing millions?
“Extrapulmonary TB represented 14% of the 6.4 million incident cases that were notified in 2017, ranging from 8% in the WHO Western Pacific...
Eight miles high – blue sky speculations on the possible origins of moxa
It’s about 500 miles from Pyongyang in North Korea to Beijing in China - at least it is if you fly as the crow does. North Korea’s Koryo...
Latent TB (Part 4) – acquired immunity and mixed infections
Let’s set the scene by starting with some much-needed good news. Protection from further infection afforded by a TB infection In the...
Latent TB (Part 3) – moxa therapy, viability in the invisibility?
So far we’ve looked at some of the complexities and uncertainties relating to these so-called ‘latent’ aspects of a pandemic plague of...
Latent MDR-TB (Part 2): the invisible within the invisible
In Part 1 we discussed the nature of latent TB (LTBI), and some of the current (and recurrent) deficiencies in treating it. In this part,...
Latent tuberculosis (part 1) - The Invisible Plague
In the last month two studies have been published which have focused our attentions on latent TB - not least because their contents have...
